Repost: Alzheimer's disease may be the last straw that

New Post Public Reply Private Reply Replies (2) Message Board
bellsandwhistles
Repost: Alzheimer's disease may be the last straw that propels medical cannabis into the mainstream and denigrates the status and influence of Big Pharma, which offers no treatment of cure for Alzheimer's. Alzheimer's has leaped from far down to  #3 as a cause of death, according to new evidence. "Deaths from Alzheimer's Six Times Higher than Previous Estimate " (Reuters)

MMJ  seems to have the answer.

The baby boomers (born 1946 - 1964) are the largest US demographic (75 million) and fastest-growing age demographic. Alzheimer's disease affects an estimated 1 in 10 people over age 65. It is the most common form of dementia and said to have no cure. New evidence ranks it as a major killer. Heart/vascular disease is #1; cancer is #2; Alzheimer's is now  #3.

It's likely  the baby-boomer bloc, who vote in high numbers and collectively control vast wealth, will not accept the status quo denial of MMJ due to the incoherent and nonsensical federal ban on MMJ/MJ nor tolerate the pawns of Big Pharma and the cartels who stubbornly resist the will of the people.

A)  Dr. Chu Chen of Lousiana State University: " There are no effective medications (i.e., Big Pharma medications) currently available for preventing and treating Alzheimer's disease or halting disease progression.

Scientists have also found that medical cannabis helps to dramatically reduce chronic pain, and reduce tremors and improve mood and communication skills in Alzheimer's sufferers.

Chen and his team found that THC treatment caused an increase in the levels of an enzyme in the hippocampus, a brain region involved in memory and learning.

Chen: "Our results suggest that the unwanted side effects of cannabis could be eliminated or reduced, while retaining its beneficial effects, by administering a COX-2 inhibitor [painkiller] along with THC for the treatment of intractable medical conditions such as Alzheimer's disease."
http://www.ibtimes.co.uk/medical-marijuana-ca...ory-524214
###

Headline: Deaths from Alzheimer's Six Times Higher than Previous Estimate

March 6, 2014. NEW YORK (Reuters Health) - Nearly half a million elderly Americans likely died from Alzheimer's disease in 2010, a figure almost six times higher than previous estimates of annual deaths, according to a new study released on Wednesday.

Dr. James Leverenz of Ohio's Cleveland Clinic Lou Ruvo Center for Brain Health: "The aging of the baby boomer population means more people living with Alzheimer's disease, which in
turn means more people dying from Alzheimer's disease since no effective treatment (i.e., Big Pharma treatments) or cure exists."

A1) Full article
Medical Marijuana 'Holds Promise for Alzheimer's Treatment'
http://www.ibtimes.co.uk/medical-marijuana-ca...ory-524214

Cannabis has been used for medical purposes for centuries for treating a wealth of conditions from chronic pain to epilepsy.

Its use in modern medicine has been stunted because of side effects, however, with the Food and Drugs Administration unwilling to approve of its use.

Researchers with Louisiana State University have found a way to reduce the side effect of memory loss associated with cannabis use and said it could be adapted as a treatment for Alzheimer's.

Scientists found that memory loss from medical marijuana could be prevented with over-the-counter painkillers such as Ibuprofen.

In findings published in the journal Cell, senior author Chu Chen said: "Our studies have solved the long-time mystery of how marijuana causes neuronal and memory impairments. The results suggest that the use of medical marijuana could be broadened if patients concurrently take a non-steroidal anti-inflammatory drug such as Ibuprofen."

The active ingredient in cannabis is tetrahydrocannabinol (THC) and some drugs based on this compound have been approved for medical use to treat nausea, vomiting and chemotherapy patients.
THC

THC destroys cancer cells and helps treat chronic pain sufferers (Reuters)

Previous research has shown that cannabis has a potent anti-cancer agent that destroys cancer cells.

Scientists have also found that medical cannabis helps to dramatically reduce chronic pain, and reduce tremors and improve mood and communication skills in Alzheimer's sufferers.

Chen and his team found that THC treatment caused an increase in the levels of an enzyme in the hippocampus, a brain region involved in memory and learning.

Testing on mice, researchers were able to reduce levels of this enzyme using drugs to stop memory problems and brain abnormalities that normally occur from repeat THC exposure.

Chen said: "There are no effective medications currently available for preventing and treating Alzheimer's disease or halting disease progression.

"Our results suggest that the unwanted side effects of cannabis could be eliminated or reduced, while retaining its beneficial effects, by administering a COX-2 inhibitor [painkiller] along with THC for the treatment of intractable medical conditions such as Alzheimer's disease."

B 1) Full article:
Deaths from Alzheimer's Six Times Higher than Previous Estimate
By Kathryn Doyle
March 6, 2014. NEW YORK (Reuters Health) - Nearly half a million elderly Americans likely died from Alzheimer's disease in 2010, a figure almost six times higher than previous estimates of annual deaths, according to a new study released on Wednesday.

The Centers for Disease Control and Prevention has estimated that approximately 5 million people are living with Alzheimer's disease in the United States, and that 83,000 die from the condition each year.

"Many people do not realize that Alzheimer's is a fatal disease," said lead author Bryan D. James of the Rush Alzheimer's Disease Center in Chicago.

"Alzheimer's disease starts in the part of your brain that controls your memory and thinking, but over years it spreads to the parts of your brain that control more basic functions such as breathing and swallowing," he told Reuters Health in an email.

Current national estimates are based on death certificates, which tend to underestimate deaths from dementia, he and his colleagues write in the journal Neurology.

They analyzed data from two existing studies that followed people age 65 and older, starting at a time when they did not have Alzheimer's. The participants were tracked for an average of eight years, with annual checkups and brain donation in the case of death.

One study followed religious orders of nuns and priests and the other followed people in retirement communities and senior housing facilities. In all, the studies tracked 2,566 people.

Over the course of the two studies, 559 participants developed Alzheimer's disease and 1,090 participants died.

People diagnosed with Alzheimer's were more than three times as likely to die as those without it. The risk was more than four times as high among participants aged 75 to 84.

Applying these figures to U.S. deaths in 2010, when the data in the two studies were collected, the authors estimate that about 500,000 people over age 75 died from Alzheimer's disease that year.

"There's no doubt that if you have Alzheimer's disease, it increases mortality risk," said Dr. James Leverenz of the Cleveland Clinic Lou Ruvo Center for Brain Health in Ohio.

But although current national estimates for Alzheimer's deaths are definitely low, he's not sure the true number is as high as the one found in this study.

"The two groups are pretty highly educated," said Leverenz, who was not involved in the new research. "They were in generally a little bit better health than the general population."

That means people in these studies could have been less likely to die from heart disease or other conditions, so a higher proportion might have died from Alzheimer's, he explained.

One of the reasons it is so hard to estimate the number of deaths from Alzheimer's is that dementia can be the underlying reason for a number of more immediate causes of death, Leverenz said. For instance, severe dementia can lead to problems swallowing, which leads to malnutrition, which can lead to pneumonia, the study authors write.

Death certificates tend to list the immediate cause of death, in this case pneumonia, and leave out dementia.

"Understanding that AD may contribute to almost as many deaths as the two leading killers in America, heart disease and cancer, is an eye-opening figure that may convince the public and policy makers that AD funding should be increased," James said.

In the study, participants lived an average of four years after an Alzheimer's diagnosis, but Leverenz said he has seen patients live with the condition for much longer - 10 or even 20 years for those with an earlier onset of disease.

"The aging of the baby boomer population means more people living with Alzheimer's disease, which in turn means more people dying from Alzheimer's disease since no effective treatment or cure exists," James said.

http://investorshangout.com/boards/message?id=1291767

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

CVB Financial Corp. Celebrates 145th Quarterly Dividend Payment

Updated Category News Views 50

CVB Financial Corp. Announces Dividend for Shareholders CVB Financial Corp. (NASDAQ: CVBF) has proudly declared a cash dividend of twenty cents ($0.20) per share for its shareholders. This notable announcement signals the Company’s 145th consecutive quarterly cash dividend, reflecting its robust financial health. The dividend was officially approved during the Company's...

Continue Reading
Clariant Strongly Denies LyondellBasell's Damages Allegation

Updated Category News Views 317

Clariant Responds to LyondellBasell's Allegations Clariant, a prominent specialty chemical company focused on sustainability, has recently found itself in the midst of a legal dispute. The company received a claim for damages associated with competition law violations linked to the ethylene purchasing market, which originated in the European Commission’s sanctions from...

Continue Reading
The Incredible Growth of Hilton Worldwide Holdings Over a Decade

Updated Category News Views 252

The Incredible Growth of Hilton Worldwide Holdings Hilton Worldwide Holdings (NASDAQ: HLT) has showcased impressive growth over the past decade, making it a notable player in the hospitality industry. With an average annual return of 17.57%, it has outperformed the market average by 5.18%. This remarkable performance highlights the potential benefits of investing in...

Continue Reading
Gentoo Media Reports Strong Q3 2024 Results and Growth

Updated Category News Views 89

Gentoo Media's Financial Performance for Q3 2024 Gentoo Media Inc., fully transitioned to an affiliate-driven business model, has celebrated yet another month of remarkable financial performance. The company has reported record revenues for the 15th consecutive quarter, evidencing its resilience and strong market positioning. Impressive Revenue Growth In its latest...

Continue Reading
Cognex Corporation's Impressive Q4 2024 Financial Performance

Updated Category News Views 208

Cognex Corporation Achieves Strong Financial Results for Q4 2024 Cognex Corporation (NASDAQ: CGNX) has recently reported its financial outcomes for the fourth quarter of 2024, showcasing a robust performance buoyed by ongoing strength in its Logistics and Semiconductor segments. Key Highlights of Q4 2024 In this quarter, Cognex's revenue reached $230 million, reflecting a...

Continue Reading